← Back to headlines
GSK Acquires Nuvalent for $10.6 Billion
Pharmaceutical giant GSK has acquired Nuvalent in a deal valued at $10.6 billion, as part of its strategy to address patent cliffs.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Negros Sugar Farmers to Receive Cash Aid Amid Pest Outbreak
just now
Philippine Senator Calls for Audit of Electricity Pass-Through Costs
just now
Philippine President Marcos Jr. to Address Nation on Corruption and Fiscal Issues
just now